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1. Introduction 
In recent years we can observe an increasing number of publications describing different 
incidents of infections, where species of Corynebacterium are isolated as the etiological factor 
of infection (Anderson et al., 2008; Campanile et al., 2009; Chiner et al., 1999; Dela et al., 
2008; Fernandez-Roblas et al., 2009; Funke et al., 1997a; Funke et al., 1997b; Lagrou et al., 
1998; Otsuka et al., 2005; Ostuka et al., 2006; Williams et al., 1993). It is a large and very 
diverse group of microorganisms, in which Corynebacterium diphtheriae is the most important 
species, with the most important human-pathogenic significance (Gomes et al., 2009; 
Wagner et al., 2011; Wilson, 1995). Strains of this species produce a strong exotoxine and are 
responsible for causing diphtheria. Well-developed procedures for diagnosis of diphtheria 
and conducted large-scale vaccinations resulted in erradication of diphtheria in most 
countries. Beside the typical human-pathogenic C. diphtheriae, the genus Corynebacterium 
comprises more than 85 different species of pathogenic significance. This type includes 
species pathogenic for animals, e.g. C. pseudotuberculosis (Baird & Fontanie, 2007; Nieto et al., 
2009), C. kutscheri (Amao et al., 2008; Suzuki et al., 1988), C. canis (Funke et al., 2009) and a 
very large group of species colonizing the skin and mucous membranes of man, which in 
favorable circumstances, may become the cause of serious infections in humans. These 
opportunistic organisms, e.g. C. jeikeium (Ifantidou  et al., 2010; Pitcher et al., 1990; Rosato et 
al., 2001), C. urealyticum (Funke et al., 1997b; Garcia-Bravo et al. 1996; López-Medrano et al., 
2008), C. amycolatum (Anderson et al., 2008; Dela  et al., 2008; Funke et al., 1997b), C. striatum 
(Campanile et al., 2009; Funke et al., 1997b; Martinem-Martinez et al., 1995; Ostuka et al., 
2006; Roberts et al., 1992), C. pseudodiphtehriticum (Chiner et al., 1999; Dorello et al., 2006; 
Freman et al., 1994; Olender & Niemcewicz, 2010), may cause infections of various course: 
mild, chronic and acute, as well as of invasive nature, life-threatening to a patient. The 
genus Corynebacterium includes also species unrelated to the human organism, e.g. C. 
glutamicum, producing L-glutamic acid and lysine, used in biotechnological processes on the 
industrial scale and in genetic studies (Katsumata et al., 1984; Serwold-Davis et al., 1987; 
Tauch et al., 1998; Wendisch et al., 2006; Valbuena et al., 2007, Yague Guirao et al., 2005).  
Application of modern molecular biology techniques in genetic studies of unknown strains 
isolated from infections resulted in the detection and description of new species such as: C. 
singulare (Riegel etal., 1997), C. auriscanis (Collins et al., 1999), C. resistens (Otsuka et al. 2005), 
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C. imitans (Funke at al., 1997a), C. sputi (Yassin & Siering, 2008) and the reclassification of 
previously inaccurately determined ones, e.g.: C. cystitidis, C. pilosum (Takahashi et al., 1995).  
In view of a widely conducted taxonomic research of species belonging to the genus 
Corynebacterium, the term "dyphteroids" has also been changed, which was used commonly for 
the opportunistic species, suggesting a direct relationship with C. diphtheriae. Nowadays 
taxonomists more and more replace it by a more universal name for this group of bacteria 
"coryneform" (Anderson et al., 2008; Balci et al., 2002; Funke et al., 1996; Funke et al., 1997b; 
Gomez-Garces et al., 2007; Lagrou et al., 1998; Ostuka et al., 2005), which seems fully justified. 
Many opportunistic strains of the genus Corynebacterium, isolated from clinical materials, 
belong to species whose characteristics determining the pathogenic effect on the human 
body have not been thoroughly recognised and characterized yet. Therefore, the assessment 
of their role as pathogens is often very difficult. Undoubtedly, the common occurrence of 
coryneform on mucous membranes and the skin may cause doubts in interpretation of their 
contribution to infections, especially when the material is sampled from places non-sterile 
physiologically and there might be a suspicion of its contamination. 
An increasing number of recognized and described incidents of infections and the observed 
increase in the number of publications on this topic is probably connected with the 
microbiological diagnostics currently carried out at a higher level and development of quick 
commercial tests for identification of species based on their biochemical properties. In 
reference to strains difficult to identify or requiring verification of uncertain biochemical 
determination, oftener methods of molecular biology are used, which has resulted in 
detection of new species and the reclassification of ones previously poorly assayed. 
Infections caused by opportunistic Corynebacterium spp. generally refer to a group of people, 
who experience symptoms of immunodeficiency. The group of patients with a particular 
risk of infection includes primarily people with immunodeficiency due to disorders of bone 
marrow activity, the ongoing processes of cancer, post surgery or urological surgery, 
invasive diagnostic procedures and patients with AIDS. The risk of infection is increased by 
long-term hospitalization, antibiotic therapy, radiotherapy, treatment with cytostatics or 
steroids. A disturbing fact is occurrence of such infections in a group of people called 
"immunocompetent", in whom no symptoms of immunodeficiency were reported before 
(Chiner et al., 1999; Frejman et al., 1994). 
The basis for treatment of infections caused by Corynebacterium spp. is taking up of an 
effective antibiotic therapy. For this group of microorganisms, until recently an obstacle in 
the evaluation of drug resistance was use of different criteria of interpretation that were 
recommended for other groups of microorganisms and determination of drug resistance 
with various methods, yet results presented by different authors have become the basis for 
information about  occurrence of strains with high resistance to antibiotics among 
opportunistic Corynebacterium spp., which indicate existence of different mechanisms of 
resistance in these strains.  
The described multidrug-resistant strains of C. jeikeium (Rosato et al., 2001; Yagye Guirao et 
al., 2005) C. amycolatum (Yagye Guirao et al., 2005; Yoon et al., 2011), C. striatum (Campanile 
et al., 2009; Martinem-Martinez et al., 1995; Otsuka et al., 2006; Roberts et al., 1992) i C. 
resistens (Otsuka et al., 2005) confirm presence in Corynebacterium spp. of different 
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mechanisms of resistance and genes, which may be differently located. Phenotypic tests of 
resistance to antibiotics have become the basis for search of the genes responsible for them 
and their transmission paths. They have also contributed to analyses and study of similarity 
in occurrence of resistance genes in other groups of microorganisms, often unrelated to the 
genus Corynebacterium, such as Staphylococcus spp. (Roberts et al., 1999), Enterococcus 
spp.(Power et al., 1995), E. coli  (Deb & Noth,1999; Serwold-Davis et al., 1990; Serwold-Davis  
et al., 1987). 
2. Mechanisms of resistance to antibiotics most commonly occurring in 
Corynebacterium spp. 
The conducted study characterizing resistance to antibiotics isolated from clinical material 
of different species of the genus Corynebacterium (Anderson et al., 2008; Fernandez-Roblas et 
al., 2009; Funke et al., 1997a; Funke et al., 1997b; Garcia-Bravo et al., 1996; Gomez-Garceset 
al., 2007; Martinem-Martinez et al., 1995; Otsuka et al., 2006; Roberts et al., 1992, Troxler R et 
al., 2001, Weiss et al., 1996 ) draw attention to the most frequently occuring  mechanisms of 
resistance to antibiotics in this group of microorganisms. The results show participation of 
extrachromosomal genetic elements in transmission of resistance genes in both pathogenic 
and potentially pathogenic - opportunistic and typically nonpathogenic ones, e.g. present in 
the soil or strains of Corynebacterium spp. (Kono et al., 1983; Vertes et al., 2005).  
Antibiotic resistance genes in species of Corynebacterium spp. are often located on large 
plasmids, e.g. resistance to tetracycline, chloramphenicol, erythromycin and streptomycin 
on plasmid pTP10 in C. xerosis (Deb & Nath, 1999; Hodgson et al., 1990), but also on 
trensposons (Delal et al., 2008). 
2.1 Resistance to macrolides, lincosamides and streptogramins B 
The occurrence of simultaneous resistance to three groups of antibiotics: macrolides, 
lincosamides and streptogramins B, determined in short as MLSB, is characteristic mainly of 
staphylococci and streptococci. It is connected with occurrence of three different 
mechanisms of the effects of activity: modification of the ribosome binding site associated 
with methylation or mutation, the mechanism of active efflux of antibiotic from the cell and 
the least significant - enzymatic inactivation of the antibiotic. The first two MLSB resistance 
mechanisms are of the highest importance. 
Methylation of the binding site causes conformational changes of the subunit 23S rRNA, 
which prevents binding of the antibiotic molecules in the peptidyltransferase center within 
the 50S ribosome subunit and leads to the blockade of the mRNA translation and inhibition 
of bacterial protein synthesis. In species of the genus Corynebacterium it is connected with 
presence of genes belonging to class erm (erythromycin ribosome methylation), encoding the 
rRNA methylase enzyme, which causes dimethylation of adenine present in the 23S rRNA 
(Arthur et al., 1990). The gene erm occurring in Corynebacterium spp, responsible for this 
mechanism of resistance has been classified as class X of genes erm (Roberts et al., 1999). 
Despite a high degree of homology between genes ermX isolated from different species of 
Corynebacterium (C. diphtheriae, C. jeikeium and C. xerosis), it has been found that they exhibit 
different locations. The gene ermX in C. diphtheriae was found within the 14.5-kbp plasmid 
pNG2 (Coyle et al., 1979), while the gene ermX in C. xerosis turned out to be located on 
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transposon Tn5432, whose carrier is the 50-kbp plasmid pTP10 (Delal et al., 2008). In the 
strain C. jeikeium (Pitcher et al., 1990) and C. striatum (Roberts et al., 1992), the gene ermX 
was found on the chromosome, which has been confirmed also in other analysed strains of 
C. jeikeium (Rosato et al., 2001). Despite detection of different locations of genes ermX in 
certain strains of C. jeikeium and C. xerosis, it is assumed that its most typical location is 
primarily the transposon Tn5432. At the same time in other examined Corynebacterium spp., 
in which the MLSB mechanism is not related to the location of genes ermX on transposon 
Tn5432, interesting results of research were obtained, indicating the possibility of 
reorganization of fragments of the transposon Tn5432 and presence of all its components in 
the strain genome (Hall et al., 1999).  
It is possible that mobile transpositional elements IS1249 containing ermX may create new 
composite transposons containing other multidrug- resistant genes. This phenomenon is 
particularly disturbing since transposition of the insertional sequence IS1249 is known for its 
capabilities to insert and transfer Tn5432 from genomes of unrelated bacteria (Rosato et al., 
2001). 
Different results of studies suggesting different locations of the detected genes ermX referred 
to the species of Corynebacterium, which were isolated from strains coming from different 
geographical regions, which may explain such diversified locations in the genome. The 
strain of C. diphthariae, containing pNG2 and C. striatum came from patients from the north-
western USA (Coyle et al., 1979; Hodgson et al., 1990; Roberts et al., 1992), C. xerosis from 
pTP10 from Japan (Tauch et al.1995), C. jeikeium from France (Rosato et al.2001) and C. 
jeikeium and C. amycolatum from Spain (Yague Guirao et al., 2005).  
It is very likely that different locations of genes ermX may indicate the possibility of acquiring 
resistance genes by multidrug-resistant strains of Corynebacterium spp. from microorganisms 
colonizing the skin or mucous membranes. ErmX occurring in C. diphtheriae is contained in 
plasmid pNG2, similar to plasmids isolated from Corynebacterium spp. occurring on the skin 
(Serwold-Davis & Groman, 1986). The replicon 2.6-kb EcoRI-ClaI fragment (oriR) may be 
possessed by many microorganisms, including a popular commensal E. coli (Deb & Nath, 1999; 
Serwold-Davis et al., 1990; Serwold-Davis et al., 1987).  
At the same time, as research indicates, the plasmid pNG2 seems an unlikely place of origin 
for genes erm occurring in Corynebacterium spp.  More likely is transposon Tn5432 associated 
with the chromosome, which may be mobile (Trauch et al., 1995). Tn5432 was also found in 
the occuring on the skin strains of Propionibacterium acnes, P. granulosum and P. avidum, 
which suggests that multidrug –resistant strains of the genus Corynebacterium may be an 
important source in horizontal transfer of resistance genes to other human pathogens (Ross 
et al., 2002). Another source, from which strains may be derived or to which they may 
arrive, is bacterial flora occurring in animals. It may be confirmed by detection of gene ermX 
in the strain of Corynebacterium spp. isolated from pasteurized milk. It showed resistance to 
erythromycin and/or spiromycin (Perrin-Guyomard et al., 2005).  
Beside gene ermX, in strains of Corynebacterium Group A with the MLSB mechanism of 
resistance, also gene erm class B has been found (Luna et al., 1999), which occurs in 
Enterococcus spp. and Streptococcus spp., which may also suggest the participation of these 
microorganisms in spread of the MLSB mechanism in Corynebacterium spp. 
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The expression of the MLSB resistance may be constitutive or induced. In the case of the 
constitutive type of resistance, active mRNA, permitting synthesis of methylase, is created 
without an inducer, while the induced MLSB - inactive mRNA is synthesized, which is 
activated only under the influence of an inducer, which allows synthesis of the enzyme. 
Occurrence of the constitutive MLSB resistance mechanism is very popular in strains of C. 
pseudodiphtheriticum, present in mucous membranes of the upper respiratory tract in humans 
(Olender & Niemcewicz, 2010). 
Formation of cross-resistance associated with the MLSB mechanism is also accompanied by 
the process of active efflux of antibiotic from the cell. In staphylococci they are transporters 
of the membrane protein nature (ETP - binding cassette), encoded by genes msrA (macrolide 
streptogramin resistance), carried on plasmids. These transporters act as a specific pump 
removing macrolides of 14 - and 15-membered lactone ring and streptogramins B from the 
bacterial cell. Macrolides of 16-membered lactose ring, lincosamides and telithromycin are 
not transported. In this case, this mechanism is referred to as MSB (Leclercq, 2002; 
Douthwaite &Champney, 2001) 
It was found that presence of gene msrA is also associated with resistance to macrolides and 
streptogramins B in strains of Corynebacterium spp. (Ojo et al., 2006) and similarly with 
production of an active transport system of the antibiotic pumped out from the cell 
(macrolide efflux proteins). Gene msrA had been previously found only in Staphylococcus 
spp. (Roberts et al., 1999). It encodes the ATP relay needed by the cell to gain energy from 
hydrolysis ATP for active transport of erythromycin and streptogramin B, and enables 
synthesis of the ABC family of transporters, i.e. multiprotein systems to actively pump out 
the antibiotic from the cell.  
In turn in reference to S.pneumoniae, S. pyogenes, S. agalactiae and other species of streptococci 
and enterococci, the efflux mechanism is associated with presence of the MCF transporters 
(macrolide-specific efflux) and refers only to macrolites with 14 - and 15-membered lactose 
rings. It does not apply to macrolites with a 16-membered lactose ring, ketolides, 
linkosamides and streptogramin B. It is associated with low levels of resistance to 
macrolides (Appelbaum, 2002). 
Gene mef, causing active efflux of macrolides from the bacterial cell was also found in 
Corynebacterium group A, C. jeikeium and strains of Corynebacterium spp. (Luna et al., 1999). 
2.2 Resistance to fluoroquinolones 
In species of the genus Corynebacterium, resistance has been also observed to 
fluoroquinolones. It is associated with point mutations within the structural gene region of 
the gyrase subunit A, which is defined as the region determining resistance to quinolones 
(QRDR - quinolone resistance determining region). 
Mutations are of the spontaneous nature, leading to changes in the amino acid sequences, on 
which depends the range of resistance to certain fluoroquinolones. The resulting level of 
resistance depends largely on the type of the amino acid that has been built-in as a result of 
mutation in place of the pre-existing one. Some of them cause a small loss of affinity and a 
slight decrease in sensitivity, other reduce potently the affinity and activity of 
fluoroquinolones. It is confirmed by studies of strains of C. macginleyi, in which resistance 
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has been found to norfloxacin, ciprofloxacin and levofloxacin. By analyzing gene gyraA 
encoding the gyrase subunit A, a change of the amino acid in position 83 in the QRDR 
region was found (Serine to Arginine), which resulted in resistance in C. macginleyi to 
norfloxacin. A double mutation has been also found, leading to amino acid changes in 
positions 83 and 87, which conditioned resistance to all fluoroquinolones. It was observed 
that double mutations occurred in Ser-83 and Asp-87 in all strains of C. macginleyi with a 
high level of resistance (Eguchi et al., 2008). 
Studies of the gene gyrA sequence were also conducted in strains of C. striatum and C. 
amycolatum (Sierra et al., 2005). A high resistance to quinolones in C.amycolatum resulted 
from a double mutation and amino acid changes in positions 87 and 97 or 87 and 88 
(unusual location of   mutation in gyrA). In the case of C. striatum mutations of amino acids 
in positions 87 and 91 occurred in gyrA, corresponding to resistance characterized by very 
high MIC values for ciprofloxacin and levofloxacin, while only moderately increased MIC 
values for moxifloxacin.  
These studies showed various complex and intricate mechanisms of resistance to quinolones 
in the studied species of Corynebacterium spp. (Sierra et al., 2005), which depend on the 
number of mutations and the type of changed amino acids. 
2.3 Resistance to tetracyclines  
Phenotypic studies constituted the basis for detection of resistance to tetracycline in 
Corynebacterium spp. In the case of C. striatum, it was found in 97% of the tested strains 
(Martinem-Martinez, 1995). These observations were confirmed by detection of the gene 
tetM, responsible for resistance to all tetracyclines, which is due to the protective effect on 
the protein ribosome with the mass of about 72-72.5 kDa (Roberts et al., 1992). 
In strains of C. striatum M82B resistance to tetracycline is associated with the region 50-kb R-
plasmid pTP10. An analysis of the nucleotide sequence revealed two reading frames called 
tetA and tetB. For analysis of the tetAB genes function, their expression in C. glutamicum was 
used and thus it was confirmed that they are responsible for resistance to tetracycline, 
oxytetracycline, and at a low level to other derivatives, such as chlortetracycline, 
minocycline and doxycycline. At the same an increased MIC value for oxacycline was found 
in this strain. This effect is associated with participation of the tetAB genes that determine 
resistance of the transport nature. It creates a powerful mechanism of active transport (efflu) 
causing pumping out of drugs from the cell via specific transport protein localized in the 
cytoplasmic membrane (Tauch et al., 1999). 
R-plasmid pTP10 found in C. xerosis also contains determinants of resistance to tetracycline 
with parallel resistance to other antibiotics, such as chloramphenicol, kanamycin and 
erythromycin (Kono et al., 1983; Tauch et al., 1995) whereas, in strains of C. melassecola, the 
species used to produce glutamate, the resistance gene to tetracycline was found on another 
mobile element - plasmid pAG1 (Deb & Nath, 1999). 
2.4 Resistance to beta-lactam antibiotics 
The common susceptibility to penicillin in toxic and nontoxic strains of C. diphtheriae made it 
one of the most frequently prescribed antibiotics in treatment of diphtheria (Wilson, 1995). 
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Despite this opinion, there have been cases observed in which it showed no efficacy. 
Phenotypic tests consisuted the basis (Von Hunostein et al., 2002), in which penicillin 
sensitivity of 24 nontoxic strains of C. diphtheriae biotype gravis was determined in the broth 
microdilution method and by Etests. The research conducted with two methods showed a 
high 98% consistency of results. MIC values for penicillin were in the range from 0.064 to 
0.250 mg/l, with simultaneous very low values for erythromycin (MIC  0.016 mg/l), 
whereas MBC (Minimal Bactericidal Concentaration) - MBC50 and MBC90 for penicillin 
were respectively 2.0 and 8.0 mg/l and 17.0 and 24.0. In 71% of the tested strains the ratio 
MBC/MIC was ≥ 32. The results of the study indicated the insensitivity (tolerance) to 
penicillin, which was confirmed by a lack of a positive effect of treatment despite the MIC 
values indicating sensitivity of the tested strains to this antibiotic. Such an effect was also 
observed in the case of tolerance to amoxicillin in the strain C. diphtheriae isolated from the 
case of endocarditis (Dupon et al., 1995). 
In other strains of Corynebacterium spp. a similar situation was found, i.e. creation of 
insensitivity to oxacillin with low MIC values. This effect was not associated with the 
existing mechanism of resistance to beta-lactam antibiotics, but with a very high phenotypic 
expression and activity of a pair of genes tetA and tetB present on the Tn3598-transposon 
Class II - 12kb, which determined resistance to tetracycline. The activity of these genes, 
which consists of powerful active pumping, resulted also in removal of a structurally 
different antibiotic, which was oxacillin (Tauch et al., 2000). 
Based on the analysis of results of phenotypic and genotypic studies of different species of 
the genus Corynebacterium showing resistance to beta-laktam antibiotics, it can be concluded 
that both resistance mechanisms organisms occur in these microorganisms, i.e. production 
of beta-laktamases and modification of penicillin-binding proteins. It is confirmed by e.g. 
resistance to penicillin (MIC 90> 4 g/ml) in strains of C. jeikeium and C. urealyticum, 
ampicillin (MIC90> 8 g/ml) (Gomez-Garces et al., 2007), in C. resistens to penicillin, 
cefazolin, cefotiam, cefmetazol, cefepime (MIC> 64 g/ml) and imipenem (MIC> 32 g/ml) 
(Otsuka et al., 2005), in strains of C. striatum to penicillin, ampicillin (MIC90 = 16 g/ml), 
cefazolin, cefotiam, cefotaxime, imipenem (MIC90> 32 g/ml) (Otsuka et al., 2006). Just like 
in hospital strains of C. urealyticum, in which resistance to penicillin and cefotaxime was 
particularly high (MIC90> 512 g/ml) (Garcia-Bravo et al., 1996).  
It can be also confirmed by an analysis of the genome sequence of C. glutamicum, which 
showed presence of four genes encoding proteins PBP (Penicillin Binding Proteins) HMW 
(high-molecular-weight), i.e. PBP1a, PBP1b, PBP2a, PBP2b, two genes encoding PBP4, 
PBP4b (low-molecular-weight) and two probably encoding beta-laktamases (Valbuena et al., 
2007). 
2.5 Resistance to glycopeptides 
An antibiotic recommended by many authors in the empirical treatment of invasive 
infections caused by species of the genus Corynebacterium is vancomycin. It is connected 
with the common sensitivity to this antibiotic of even multidug-resistant species, which pose 
the greatest problems in infections. It refers to such species as C. jeikeium, C. resistant, C. 
amycolatum and C. striatum (Wiliams et al., 1993). Unfortunately, still cases of isolated strains 
of C. aquaticum and C. group B1 resistant to vancomycin have been reported. 
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Only single cases are described, in treatment of which other alternative antibiotics give very 
good results. An example might be a case of infection in a 44-year-old patient with 
endocarditis 4 months after a prosthetic mitral valve (Barnas et al., 1991). The strain of 
Corynebacterium spp. isolated from the blood turned out resistant to vancomycin and 
penicillin G, erythromycin, gentamicin and rifampicin. The use of imipenem and 
ciprofloxacin resulted in an effective cure of the infection. 
In related species of Coryneform Oerskovia turbata 892 and Arcanobacterium (former 
Corynebacterium) haemolyticum 872, resistance to vancomycin and teicoplanin was found of 
the constitutive nature. Presence of the VanA gene was detected, found on plasmids of 15 
and 20 kb. In strains of A. haemolyticum 872 the VanA gene sequence turned out the same as 
in vancomycin-resistant Enterococcus faecium BM4147. In the case of O. turbata 892 a change 
of sequence occurred in three points. Species A. haemoliticum and O. turbata show a natural 
sensitivity to vancomycin and teicoplanin, and resistance found in the tested strains resulted 
from presence of the VanA gene (Power et al., 1995). The resistance phenotype associated 
with presence of the VanA gene is characterized by a high degree of resistance to 
vancomycin and teicoplanin.  
2.6 Resistance to chloramphenicol 
Resistance genes to chloramphenicol were detected on plasmids - in the strain 
Corynebacterium spp. on the pXZ10145 plasmid - 5.3 kb  and in C. xerosis on pTP10 - 45.0 kb 
(Deb & Nath, 1999). In C. striatum strain M82B (former C. xerosis M82B) (Tauch et al., 1998) 
chloramphenicol resistance gene cmx (chloramphenicol and exports) was detected as an 
integral part of the transposon Tn5564, which contains a complete copy of the insertion 
sequence IS1513. The cmx gene is responsible for encoding of a specific protein 
(transmembran chloramphenicol efflux protein), which inhibits the passage of the antibiotic 
into the cytoplasm, and gives the bacetrial cell resistance to chloramphenicol. 
3. Problems with diagnostic of infection by coryneform  
The increasing isolation of multidrug-resistant strains of the genus Corynebacterium from 
clinical materials draws attention to the emerging issues related to treatment of infections 
caused by this group of opportunistic bacteria. The problem is all the more important since 
the infections often concern diagnostically difficult cases, long-hospitalized patients, the 
chronically ill, often with an accompanying disease causing immunosuppression. The 
underrated contribution of coryneform in infections may lead to therapeutic errors. Their 
common occurrence on the mucous membranes and skin causes doubts about their 
recognition as the etiologic factor of the infection.  
The next problem, that may determine the accuracy of microbiology result as well as 
confirmation of the presence of opportunistic Corynebacterium spp. in infection, is a choice of 
appropriate culture method – bacterial culture media, which composition supports the 
growth of different coryneforms species. It is applied mostly for lipophilic species, as C. 
jeikeium, C. urealyticum. It is very important to identify the isolated strains precisely, as this 
enables tracking multi drug-resistance in specific strains, their existence on specific areas 
and routes of transmission. These informations are specifically important for hospital areas, 
facilitating to make proper decision on limiting these types of infections.  
www.intechopen.com
 
Mechanisms of Antibiotic Resistance in Corynebacterium spp. Causing Infections in People 
 
395 
Accurate microbiological diagnostics of infections caused by species of the genus 
Corynebacterium, identification of strains of the isolated species and determination of 
antibiotic susceptibility with methods enabling determination of the MIC values permit 
assessment of the existing and emerging mechanisms of drug resistance and result in 
making right decisions about the most appropriate antibiotic therapy for a given case. It is 
extremely important to apply correct interpretation criteria of the determined drug 
resistance for species of the genus Corynebacterium, specific for this group of 
microorganisms, based on the established and generally accepted recommendations 
(Clinical and Laboratory Standards Institute [CLSI], 2006; Łętowska & Olender, 2010). 
Application of methods of molecular biology and examination of resistance genes, their 
locations and transmission paths is a very important direction of research on monitoring of 
resistance mechanisms in coryneform and gives the ability to track and determine their role 
in transmission of genes also among other species. 
4. Antibiotic therapy used in infections of Corynebacterium spp. 
The basis for monitoring of the emerging multi-drug resistant strains for all bacteria, as well 
as species of the genus Corynebacterium, is conducting research characterizing their 
sensitivity to antibiotics, which is potentially useful in treating infections. Publication of 
such data is extremely important due to tips received about the most effective antibiotic 
therapy for a given group of microorganisms.  
An analysis of sensistivity to antibiotics of a large group of strains of C. urealyticum, C. 
amycolatum, C. jeikeium, C. coyleae, C. striatum, C. aurimucosum and C. afermentans was 
conducted with assays using Etests (Fernandez-Roblas et al., 2009). The authors found that 
strains of all tested species were susceptible to glycopeptides, linezolid, 
chinupristin/dalphopristin and daptomycin, which was also confirmed in other studies 
(Funke et al., 1997a; Funke et al., 1997b). 
The results obtained from research done in Italy, involving strains of C. striatum isolated 
from different infections, also indicated the need of analysis of drug resistance in 
Corynebacterium. Genetic studies of strains of C. striatum MDR (multidrug-resistant) revealed 
presence of a multidrug-resistant clone, whose strains isolated from cases of pneumonia, 
catheter related bacteremia and wound infections showed, despite resistance to other classes 
of antibiotics, susceptibility to glycopeptides, tigecyclin, chinupristyn/dalphopristin, 
daptomycin and linezolid (Campanile et al., 2009). 
One of the most resistant species, which causes the biggest problems in hospitals and is 
frequently isolated from infections in hospitalized patients, is C. jeikeium. The study of 66 
strains of C. jeikeium (Johnson et al. 2004) showed resistance to penicillin in all of them, in 
94% resistance to erythromycin, and in 74% to tetracycline. Twenty-two strains of other 
examined species of the genus Corynebacterium had a significantly lower level of the 
resistant. But what is extremely important, all examined strains were susceptible to 
vancomycin (MIC = 0.5-4.0 mg/l), linezolid (MIC = 0.5-2.0 mg/l) and daptomycin (MIC ≤ 
1mg/l) with the exception of two isolates of C. auaticum, whose MIC for daptomycin was 8 
mg/l. At the same time effecacy of daptomycin was confirmed in the successfully applied 
combination with rifampicin in a patient with endocarditis caused by C. amycolatum (Dala et 
al., 2008) i C. striatum (Shah & Murillo, 2005). 
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Linezolid, as shown in published works, was also characterized by a very good action. High 
activity of linezolid was found in studies of 190 strains of coryneform (Gomez-Garces et 
al.,2007). It confirmed the possibility of equally successful application of this antibiotic in 
infections caused by Coryneform. 
Diversity of antibiotic resistance in species of the genus Corynebacterium is strictly connected 
with the locations, in which the tested strains occur. As found in the conducted studies 
(Garcia-Bravo et al., 1996) strains of C. urealyticum coming from hospitalized patients show 
significantly higher resistance to antibiotics than those isolated from outpatients, from 
outside of the hospital environment. An analysis of frequency and duration of antibiotic 
therapy used in patients from both groups of respondents was conducted. It confirmed 
unequivocally that the hospital environment and more frequently used antibiotics in the 
hospitalized patients is conducive to occurence of multidrug-resistant strains, and the 
hospital environment in which such patients stay is the place from which strains of C. 
urealyticum came, causing infections in the hospitalized patients. At the same time 
considerably lower resistance to antibiotics of isolates coming from the outpatients indicates 
that the strains of C.urealyticum most likely are derived from microflora colonizing the skin 
of the examined outpatients. 
A very disturbing fact is discovery of new multidrug-resistant species of the genus 
Corynebacterium, which suggests a progressive character of multidrug-resistance occurring 
in this group. It is confirmed by a description of a new multidrug-resistant species of C. 
resistens in 2005. It is lipophilic, with low fermentation properties (it ferments glucose), does 
not reduce nitrates, does not produce urease and pyrazinamidase. It is characterized by 
resistance to penicillin and cephalosporins (MIC  64 µg/ml), imipenem (MIC  32 µg/ml), 
aminoglycosides (MIC  3 µg/ml 2), macrolides (MIC  16 µg/ml), quinolones (MIC  32 
µg/ml) and sensitivity to teicoplanin (MIC  0.5 µg/ml) and vancomycin (MIC = 2 µg/ml) 
(Otsuka et al., 2005). 
5. Conclusion 
Presented by several authors results of their studies on antibiotics resistance show, that even 
though Corynebacterium spp. are the members of the normal flora, they are not universally 
susceptible to antibiotics, as could be expected. Opportunistic Corynebacterium spp., until 
now considered as bacteria of low pathogenicity, may pose a diagnostic and therapeutic 
problems, as they are more and more commonly isolated from serious, life-threatening 
invasive infections. Observed in many cases multi drug-resistance may be connected with 
the possibility to acquire resistance genes by gene transfer within bacteria regarded as 
normal flora present in large number on a given body area (skin, mucous membranes). Drug 
resistance occurrence in opportunistic species is the result of antibiotics overuse. It is 
obvious that antibiotics used also influence on saprophytic bacteria. Resulting selection of 
resistant strains is commonly known and regarded as important process leading to multi 
drug-resistance. For these reasons, analysis of the process in opportunistic Corynebacterium is 
an important element in monitoring new multi drug-resistant strains derived from 
saprophytic flora, mostly in infections in patients from risk groups, under 
immunosuppression, hospitalized for long time. Studying mechanisms of drug resistance on 
the basis of phenotypic and genotypic expression is important for proper antibiotic 
therapies in infections caused by this group of microorganisms. 
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Studies on sensitivity to antibiotics of different multidrug-resistant species of the genus 
Corynebacterium indicate that the highest efficacy in treatment of infections is shown by 
glycopeptides, linezolid, daptomycin, tigecyclin and chinupristin/dalphopristin. 
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views on new strategies for interventions in antibiotic-resistant bacterial strains cases and outbreaks. As a
consequence, the recently developed techniques in this field will contribute to a considerable progress in
medical research.
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